BioMaxima S.A. (WSE: BMX)
Poland flag Poland · Delayed Price · Currency is PLN
11.80
-0.05 (-0.42%)
Jan 21, 2025, 5:00 PM CET

BioMaxima Revenue

BioMaxima had revenue of 12.46M PLN in the quarter ending June 30, 2024, with 16.15% growth. This brings the company's revenue in the last twelve months to 48.97M, up 1.61% year-over-year. In the year 2023, BioMaxima had annual revenue of 46.79M, down -67.48%.

Revenue (ttm)
48.97M
Revenue Growth
+1.61%
P/S Ratio
1.02
Revenue / Employee
425.86K
Employees
115
Market Cap
49.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 202061.28M30.67M100.19%
Dec 31, 201930.61M-1.41M-4.40%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.34B
Synektik Spólka Akcyjna 624.80M
Voxel 492.41M
Celon Pharma 209.54M
Selvita 334.42M
Ryvu Therapeutics 91.18M
Centrum Medyczne ENEL-MED 680.32M
Mercator Medical 488.78M
Revenue Rankings